In accordance with Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Dolphin Medical Services has submitted the Unaudited Financial Results for the 3rd Quarter and Nine months ended 31.12.2024 along with the Limited Review Report for the 3rd Quarter ended 31.12.2024. The results were reviewed by the Audit Committee and approved and taken on record by the Board of Directors at their meeting held on 10th February 2025. The Meeting of the Board commenced at 6:30 PM and concluded at 7:45 PM.
The above information is a part of company’s filings submitted to BSE.